Dr. Marilyn S. Albert's lab conducts groundbreaking research on Alzheimer's disease, focusing on identifying biomarkers that indicate cognitive decline in individuals who are initially cognitively healthy. By tracking participants over several decades, the lab aims to uncover the earliest changes associated with Alzheimer's, paving the way for preventive measures and interventions. The research not only enhances our understanding of Alzheimer's progression but also looks into the role of lifestyle factors in cognitive health.

Dr. Dwight E. Bergles' lab at Johns Hopkins University focuses on understanding a specific type of brain cell called oligodendrocyte precursor cells (OPCs). These cells play critical roles in maintaining and repairing the brain's myelin, which is essential for proper neural signaling. The lab is developing advanced tools to study how these cells respond to aging and diseases like Alzheimer's, aiming to uncover their potential in promoting brain health and regeneration.

Dr. Seth Blackshaw's lab at Johns Hopkins University focuses on understanding how retinal progenitor cells develop and differentiate into various cell types in the retina. Through their research, they explore the genetic networks that control these processes and aim to find new ways to reprogram glial cells to generate neurons that are crucial for vision. Their work has important implications for developing therapies for vision restoration in diseases like macular degeneration and glaucoma.

Dr. Peter A Calabresi’s research lab focuses on understanding how multiple sclerosis (MS) progresses and how we can predict its course in patients. By using advanced imaging techniques like MRI and optical coherence tomography, they study changes in the brain and retina that occur as MS advances. The goal is to develop better tools to monitor patients and guide treatment decisions, ultimately improving care for those with MS.

Dr. Hey-Kyoung Lee's research lab focuses on understanding how the brain adapts to sensory loss, especially in cases of vision and audition. By investigating neural circuits and synaptic mechanisms in the adult brain, the lab aims to reveal how one sense can compensate for another following deprivation. This work has implications for developing therapies to enhance sensory function in individuals with sensory impairments.

Dr. John E. Desmond's lab at Johns Hopkins University focuses on how the cerebellum contributes to cognitive processes, particularly in understanding sequences in memory and language. The research aims to explore the cerebellum's role in cognitive functions through functional and structural neuroimaging studies in patients with cerebellar damage. By applying techniques like transcranial magnetic stimulation (TMS), the lab investigates the brain mechanisms that support sequence prediction and violations, enhancing our knowledge of cognitive functions and related disorders.

Dr. Xinzhong Dong's lab focuses on understanding chronic itch, a condition that severely impacts patients' lives. They study the role of specific receptors in sensory neurons responsible for itch sensation, especially in response to various diseases and drugs. Their work aims to reveal the biological mechanisms behind itch and facilitate the creation of new treatments for it.

Dr. Emily Johnson's research lab at Johns Hopkins University focuses on understanding late-onset epilepsy, particularly how epigenetic factors and chronic health conditions contribute to cognitive decline in older adults. The lab explores the relationship between environmental exposure, genetic markers, and cognitive performance to aid dementia prevention strategies. This work is especially relevant for the over 250,000 older adults in the U.S. suffering from this condition.

Dr. Barbara Stauch Slusher's lab at Johns Hopkins University focuses on innovative ways to combat age-related muscle loss, known as sarcopenia. The research specifically investigates a targeted delivery system using dendrimers, which are nanoparticles that can deliver drugs effectively to the right cells, such as activated macrophages in aging muscles. By optimizing a potential treatment that inhibits a specific enzyme involved in muscle degradation, the lab aims to improve muscle function and quality of life for older adults.

Dr. Argye E. Hillis's lab focuses on understanding how language deficits caused by stroke can improve over time. They study different recovery mechanisms, including the restoration of blood flow to affected brain areas and the reorganization of brain networks. The lab aims to identify factors that can predict individual recovery patterns, helping to develop personalized treatments for people with aphasia.

Dr. Richard Leigh's lab at Johns Hopkins University focuses on understanding cognitive decline after strokes. They investigate how damage to the blood-brain barrier may contribute to memory problems and brain changes in stroke survivors. By studying brain imaging and developing new diagnostic methods, the lab aims to identify patients at risk for dementia and improve treatment strategies.

Dr. Cherie L Marvel's lab studies how Lyme disease affects the brain, particularly after treatment when some patients experience lingering neurological symptoms. They investigate the relationship between changes in brain structure, specifically white matter, and cognitive performance over time. By using advanced imaging techniques and blood tests, the lab aims to uncover the biological mechanisms behind these cognitive issues, potentially leading to better diagnostic and therapeutic strategies for patients.

Dr. Elisabeth Breese Marsh's lab at Johns Hopkins University focuses on understanding and addressing vascular cognitive impairment in patients who have experienced minor strokes. The research aims to identify noninvasive digital biomarkers to predict cognitive decline, leveraging advanced neuroimaging techniques like magnetoencephalography (MEG) and electroencephalography (EEG) combined with deep learning methods. Ultimately, their goal is to develop tools that can help identify patients at risk for cognitive impairment after stroke, leading to timely interventions that could improve patient outcomes.

Dr. Kathryn C. Fitzgerald's lab focuses on understanding multiple sclerosis (MS), a complex disease affecting the nervous system. The lab investigates metabolic changes in individuals with MS to identify biomarkers that can predict disease progression and reveal new therapeutic targets. Using advanced analysis of metabolic profiles, they aim to enhance personalized approaches to MS treatment and improve outcomes for patients.

Dr. Kelly Alexander Mills's lab at Johns Hopkins University focuses on understanding the role of microglia, the brain's immune cells, in Parkinson's disease. The research aims to explore how microglial activation affects cognitive and motor functions in patients, particularly in those with varying degrees of disease severity. By developing and using specialized imaging techniques, the lab seeks to correlate microglial activity with cognitive decline and other pathological biomarkers, which may lead to new treatment strategies for Parkinson's disease.

Dr. Michael I. Miller leads a research lab at Johns Hopkins University focused on understanding how Alzheimer's disease affects specific brain regions, particularly the entorhinal cortex, which deteriorates early in the disease. The lab employs advanced MRI techniques along with histological and molecular analyses to correlate structural brain changes with cognitive impairment and disease progression. This research aims to develop new MRI-based biomarkers that could aid in the early detection and treatment of Alzheimer's disease.

Dr. Ulrich Mueller's laboratory at Johns Hopkins University focuses on understanding the function of hair cells in the inner ear, which are critical for hearing. The lab studies specific genes linked to hearing loss and how those genes affect the development and function of these hair cells. Researchers investigate the mechanisms of signal transmission in auditory circuits and the impact of genetic mutations on hearing capability.

Dr. Ted Dawson's lab at Johns Hopkins focuses on understanding the mechanisms of neurotoxicity related to stroke and neurodegenerative diseases. They investigate a specific form of cell death called parthanatos, particularly how the enzyme associated with it, known as PAAN/MIF, contributes to injury in neurons. The ultimate goal of the research is to develop innovative therapies to protect neurons from damage and improve outcomes for patients suffering from strokes and similar conditions.

Dr. Carlos A Pardo-Villamizar's lab at Johns Hopkins University focuses on understanding neurosarcoidosis, a condition that affects the nervous system and arises from a systemic inflammatory disorder. The research aims to identify specific biomarkers and immune profiles linked to the disease, explore the role of genetic signatures, and uncover potential antigens or pathogens that may trigger the inflammatory response. This work seeks to better characterize patient phenotypes and improve therapeutic strategies for neurosarcoidosis.

Dr. Alyssa Coyne's lab investigates the molecular mechanisms underlying neurodegenerative diseases like Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). The research focuses on how disruptions in the nuclear pore complex affect cellular functions in neurons and contribute to disease progression. By studying induced pluripotent stem cell-derived neurons and human tissues, they aim to uncover potential therapeutic targets to prevent or mitigate neurodegeneration.